- What are sponsors doing now to plan ahead and to position studies to return to full activity as precautions release?
- How can sites prepare for the wave of study restarts? What can be done now- even remotely- to maintain contact with participants, sponsors and vendors?
- What will be different about our research studies, procedures and practices as we move into a post-COVID world?
Request a Genetics in Clinical Trials training sessionWhat You'll Learn
Most Recent Flipbooks
16 industry experts share shifts and trends that will inform clinical research in 2020 and beyond.
From cardiovascular adverse events to complex dosing regimens, oncology trials present unique safety-related considerations.
Something Has to Give: The Current Unsustainable Approach to Safety Reporting Puts Trials and Patients at Risk
In this interview, Jesse Kooker, MPH, VP of Clinical Data Sciences at WCG's MedAvante-ProPhase, looks at the clinical development industry through the lens of data analytics.